Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation [PDF]
, 2016 Ceftolozane-tazobactam has potent activity against Pseudomonas aeruginosa , a pathogen associated with cystic fibrosis (CF) acute pulmonary exacerbations (APE).
Cies, Jeffrey J. +5 more
core +2 more sources
2253. Comparison of Outcomes Between Patients with and without Cystic Fibrosis Treated with Ceftolozane–Tazobactam for Pseudomonas aeruginosa Infections [PDF]
, 2019 Michael J Trisler +3 more
openalex +1 more source
In Vitro Synergistic Antimicrobial Activity of Combinations of Meropenem, Colistin, Tigecycline, Rifampin, and Ceftolozane/Tazobactam Against Carbapenem-Resistant Acinetobacter Baumannii [PDF]
, 2021 Yong Guk Ju +6 more
openalex +1 more source
Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital [PDF]
, 2019 Objectives. Our objective was to evaluate the in vitro activity of ceftolozane-tazobactam against multidrug resistant (MDR) and extensively drug-resistant (XDR) non metallo-ß-lactamase producing Pseudomonas aeruginosa clinical isolates at Hospital ...
Fernandez Esgueva, Marta +8 more
core
In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis [PDF]
, 2017 Patrick Grohs +7 more
openalex +1 more source
Cost-effectiveness Analysis of CTZ/TAZ for the Treatment of Ventilated Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia in Japan [PDF]
, 2023 聖路加国際大学修士(公衆衛生学 ...
Risako Takaya, 高家, 理紗子
core
Role of Class I, II and III Integrons in Multidrug Resistance in Pseudomonas aeruginosa Isolated from Nosocomial Hospital [PDF]
, 2016 Aims: The increasing usage of antibiotics can cause resistance to the treatment of infections, which can caused by bacteria, e.g. Pseudomonas aeruginosa. The aim of this study was to trace the class I, II and III integrons in isolates of P. aeruginosa of
Momtaz, H., Nourbakhsh, F.
core +1 more source
Antibiotics, 2019 Infections, with multidrug-resistant Pseudomonas aeruginosa, are a major concern in the pediatric intensive care unit, especially in immunocompromised patients.
Ahmed Zikri, Kamal El Masri
doaj +1 more source
Cost-Effectiveness of Ceftolozane/Tazobactam Plus Metronidazole as Empiric Therapy for the Treatment of Complicated Intra-Abdominal Infections in Colombia [PDF]
, 2018 Pieralessandro Lasalvia +8 more
openalex +1 more source
2175. In vitro Potency of Ceftolozane/Tazobactam and Other Antipseudomonal β-Lactams Against P. aeruginosa [PDF]
, 2018 Safa S. Almarzoky Abuhussain +2 more
openalex +1 more source